Novartis: all 3,900 studies
Page 8 of 39. Open to participants first (226), then studies with results posted, then the rest; newest registration first within each.
- Assessment of Switching From Salmeterol/Fluticasone to Indacaterol/Glycopyrronium in a symtomaticCOPD Patient CohortCompletedNCT02516592Phase 4Results posted
- Safety and Efficacy Study of LHW090 in Resistant Hypertension PatientsCompletedNCT02515331Phase 2Results posted
- GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera®CompletedNCT02514772Phase 3Results posted
- Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.CompletedNCT02487498Phase 3Results posted
- Efficacy and Safety Study of QVA149 in COPD PatientsCompletedNCT02487446Phase 3Results posted
- Efficacy and Tolerability of Topical LFX453 for External Genital WartsCompletedNCT02482428Phase 2Results posted
- Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSUCompletedNCT02477332Phase 2Results posted
- A Study to Assess the Efficacy and Tolerability of Diclofenac Potassium Soft Gelatin Capsules Compared With Ibuprofen Tablets in Patients With Moderate to Severe Postoperative Dental PainCompletedNCT02476422Phase 3Results posted
- Study of Secukinumab Compared to Fumaderm® in Adults With Moderate to Severe Psoriasis.CompletedNCT02474082Phase 3Results posted
- Secukinumab Dosage Optimisation in Partial Responders With Moderate to Severe Plaque-type PsoriasisCompletedNCT02474069Phase 3Results posted
- Pediatric Study in Children and Adolescents With Severe Plaque PsoriasisCompletedNCT02471144Phase 3Results posted
- Effect of LIK066 on Body Weight in Patients With Elevated Body Mass IndexCompletedNCT02470403Phase 2Results posted
- A 24-week Off-drug Extension Study in Sarcopenic Elderly Who Completed Treatment in the 6-month Core StudyCompletedNCT02468674Phase 2Results posted
- Study of Efficacy and Safety of LCZ696 in Japanese Patients With Chronic Heart Failure and Reduced Ejection FractionCompletedNCT02468232Phase 3Results posted
- Study of Efficacy and Safety of Osilodrostat in Cushing's SyndromeCompletedNCT02468193Phase 2Results posted
- Ceritinib Rare Indications Study in ALK+ TumorsTerminatedNCT02465528Phase 2Results posted
- 3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir StudyTerminatedNCT02465203Phase 3Results posted
- Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.CompletedNCT02460224Phase 1/2Results posted
- A Study to Evaluate the Safety of a Single Intravenous (IV) Dose of Orbactiv (Oritavancin) in Participants on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI)CompletedNCT02452918Phase 4Results posted
- LDK378 in Patients With ALK Positive NSCLC Previously Treated With Alectinib.CompletedNCT02450903Phase 2Results posted
- Corrected VA With Long-Term Follow-Up After AcrySof® Intraocular Lens (IOL) ImplantationCompletedNCT02450799Not applicableResults posted
- A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251CompletedNCT02449018Phase 2Results posted
- Study of Efficacy and Safety of CTL019 in Adult DLBCL PatientsCompletedNCT02445248Phase 2Results posted
- Effect of QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) on Cardiac Function in COPD PatientsCompletedNCT02442206Phase 4Results posted
- Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.CompletedNCT02437318Phase 3Results posted
- Study of Efficacy and Safety of CTL019 in Pediatric ALL PatientsCompletedNCT02435849Phase 2Results posted
- Efficacy Study of MCS110 Given With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC)CompletedNCT02435680Phase 2Results posted
- Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron OverloadCompletedNCT02435212Phase 2Results posted
- Study of Efficacy of CDZ173 in Patients With APDS/PASLICompletedNCT02435173Phase 2/3Results posted
- A Study to Evaluate Safety and Immunogenicity of Trivalent Influenza Vaccine, Formulation 2015 Southern Hemisphere, When Administered to Healthy Adult Subjects.CompletedNCT02427750Phase 2Results posted
- Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.CompletedNCT02422615Phase 3Results posted
- Efficacy, Safety, and Pharmacokinetics Study of CJM112 in Hidradenitis Suppurativa PatientsCompletedNCT02421172Phase 2Results posted
- Effects of Indacaterol in Symptomatic COPD Patients With Low Risk of ExacerbationsCompletedNCT02418468Phase 4Results posted
- Study of Oral cMET Inhibitor INC280 in Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1)CompletedNCT02414139Phase 2Results posted
- Plaque Psoriasis Efficacy and Safety With SecukinumabCompletedNCT02409667Phase 3Results posted
- Phase I/II Study of PDR001 in Patients With Advanced MalignanciesCompletedNCT02404441Phase 1/2Results posted
- Safety, Tolerability, and Efficacy Study of LFX453 in Actinic Keratosis PatientsCompletedNCT02404389Phase 2Results posted
- Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic ArthritisCompletedNCT02404350Phase 3Results posted
- Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) SubjectsCompletedNCT02404025Phase 2Results posted
- Femtosecond Laser Assisted Cataract Surgery in Intumescent CataractsCompletedNCT02403206Not applicableResults posted
- Open Label Study to Evaluate the Safety and Efficacy of Lenalidomide With MOR00208 in Patients With R-R DLBCLCompletedNCT02399085Phase 2Results posted
- Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIACompletedNCT02396212Phase 3Results posted
- Safety and Clinical Utility Study of SSEC Fentanyl 40 mcg for Acute Post-op Pain Management in Pediatric ParticipantsCompletedNCT02395653Phase 3Results posted
- A 24-week, Multicenter, proSpective stUdy to Evaluate the PASI 90 Clinical Response Rate and the Safety PRofile of sEcukinuMab 300 mg in Cw6-negativE and Cw6-positive Patients With Moderate to Severe Chronic Plaque-type Psoriasis (SUPREME)CompletedNCT02394561Phase 3Results posted
- Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1)CompletedNCT02382913Phase 1Results posted
- Study to Evaluate the Efficacy of N-acetylcysteine (NAC) in the Treatment of the Common Cold and CoughCompletedNCT02379637Phase 2Results posted
- RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of PrematurityCompletedNCT02375971Phase 3Results posted
- Fingolimod Effect on Cytokine and Chemokine LevelsCompletedNCT02373098Phase 4Results posted
- A Study of the Efficacy and Safety of NVA237 in Patients With Moderate to Severe COPDCompletedNCT02371629Phase 4Results posted
- Study of Efficacy of Ranibizumab in Different Regimens in Patients With Diabetic Macula EdemaCompletedNCT02366468Phase 4Results posted
- LME636 in the Relief of Persistent Ocular Discomfort in Subjects With Severe Dry Eye DiseaseCompletedNCT02365519Phase 2Results posted
- Secukinumab Study in PSOriasis Exploring pruRITUS Intensity and Lesional BiomarkersCompletedNCT02362789Phase 3Results posted
- LHA510 Proof-of-Concept Study as a Maintenance Therapy for Patients With Wet Age-Related Macular DegenerationCompletedNCT02355028Phase 2Results posted
- Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin AnaloguesCompletedNCT02354508Phase 3Results posted
- Long-term Monitoring of Growth and Development of Pediatric Patients Previously Treated With EverolimusCompletedNCT02338609Phase 4Results posted
- A Phase II Study to Evaluate the Efficacy and Safety of Oral Ceritinib in Patients With ALK-positive NSCLC Metastatic to the Brain and/or to LeptomeningesCompletedNCT02336451Phase 2Results posted
- Efficacy and Safety of QGE031 Compared With Placebo in Patients Aged 18-75 Years With AsthmaTerminatedNCT02336425Phase 2Results posted
- Study of Safety and Efficacy of EGFR-TKI EGF816 in Combination With cMET Inhibitor INC280 in Adult Patients With EGFR Mutated Non Small Cell Lung Cancer.TerminatedNCT02335944Phase 1/2Results posted
- A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 StudiesCompletedNCT02334748Phase 3Results posted
- Dose Range Finding Study of Bimagrumab in SarcopeniaCompletedNCT02333331Phase 2Results posted
- Study of Efficacy and Safety of Omalizumab in Refractory Chronic Spontaneous Urticaria PatientsCompletedNCT02329223Phase 3Results posted
- 99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS)TerminatedNCT02328027Phase 1/2Results posted
- FGF401 in HCC and Solid Tumors Characterized by Positive FGFR4 and KLB ExpressionCompletedNCT02325739Phase 1/2Results posted
- Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic SolutionCompletedNCT02325518Phase 4Results posted
- Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung CancerTerminatedNCT02323126Phase 2Results posted
- Long-term Follow-up of Fingolimod Phase II Study PatientsCompletedNCT02307838Phase 4Results posted
- Safety and Blood Donations in Adults Vaccinated With rMenB+OMV NZ.CompletedNCT02305446Phase 3Results posted
- A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent ProgressionCompletedNCT02300987Phase 2Results posted
- ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of CanakinumabCompletedNCT02296424Phase 3Results posted
- Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast CancerTerminatedNCT02294786Phase 2Results posted
- 16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic ArthritisCompletedNCT02294227Phase 3Results posted
- Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.CompletedNCT02292446Phase 3Results posted
- Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's SyndromeCompletedNCT02291029Phase 2Results posted
- Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects With Acute Blunt Trauma InjuriesCompletedNCT02290821Phase 3Results posted
- Study of Panobinostat in Combination With Bortezomib and Dexamethasone in Japanese Patients With Relapsed/Refractory Multiple MyelomaCompletedNCT02290431Phase 2Results posted
- Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast CancerCompletedNCT02278120Phase 3Results posted
- A Phase II, Open Label, Multiple Arm Study of AUY922, BYL719, INC280, LDK378 and MEK162 in Chinese Patients With Advanced Non-small Cell Lung CancerCompletedNCT02276027Phase 2Results posted
- A Study of Imatinib and Nilotinib in Patients With Chronic Myelogenous Leukemia in Chronic PhaseCompletedNCT02272777Phase 3Results posted
- A Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects Experiencing Delayed Onset Muscle SorenessCompletedNCT02271854Phase 3Results posted
- An Open Label Study of LMI070 (Branaplam) in Type 1 Spinal Muscular Atrophy (SMA)CompletedNCT02268552Phase 1/2Results posted
- Efficacy and Safety Study of CSJ148 in Stem Cell Transplant PatientsCompletedNCT02268526Phase 2Results posted
- Efficacy and Safety of Subcutaneous Secukinumab in Adults With Moderate to Severe Scalp PsoriasisCompletedNCT02267135Phase 3Results posted
- Compare Safety/Efficacy of Labeled vs Wait-Extend Regimen of Lucentis in Turkish Patients With VI Due to DMECompletedNCT02262260Phase 3Results posted
- A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) PatientsCompletedNCT02259088Phase 3Results posted
- Systemic Vascular Endothelial Growth Factor (VEGF) Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Neovascular Age-related Macular DegenerationCompletedNCT02257632Phase 4Results posted
- Safety and Immunogenicity of Two Trivalent Subunit Influenza Vaccines in Healthy Adult SubjectsCompletedNCT02256488Phase 3Results posted
- Safety and Immunogenicity of an Adjuvanted Trivalent Influenza Vaccine in Children 6 to <72 Months of Age in Mexico.CompletedNCT02255279Phase 3Results posted
- Study of Long-term Safety, Efficacy Tolerability of BYM338 in Patients With Sporadic Inclusion Body MyositisCompletedNCT02250443Phase 2/3Results posted
- Evaluation of Lung Clearance Index in Cystic Fibrosis (CF) Patients, Infected With P.AeruginosaTerminatedNCT02248922Phase 4Results posted
- A Multicenter, 4-week Crossover (Total Duration 12 Weeks) to Determine the Impact of QVA149 on Nocturnal Oxygen Levels in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02233543Phase 4Results posted
- Long-term, Open-label, Multicenter Study Assessing Long-term Cardiovascular RisksCompletedNCT02232061Phase 4Results posted
- Study of Efficacy and Safety of CTL019 in Pediatric ALL PatientsCompletedNCT02228096Phase 2Results posted
- Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection FractionCompletedNCT02226120Phase 3Results posted
- CCFZ533X2201 - PoC Study in de Novo Renal TransplantationCompletedNCT02217410Phase 1/2Results posted
- Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast CancerTerminatedNCT02213042Phase 2Results posted
- Prospective Cohort Study for the Real - Life Effectiveness Evaluation of GlycOpyrronium With IndacatERol Combination in the Management of COPD in Canada (POWER Study)CompletedNCT02202616Phase 4Results posted
- A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)CompletedNCT02201290Phase 3Results posted
- Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis PatientsTerminatedNCT02190604Phase 1/2Results posted
- LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)CompletedNCT02187783Phase 2Results posted
- Ceritinib (LDK378) for Patients Whose Tumors Have Aberrations in ALK or ROS1 (SIGNATURE)TerminatedNCT02186821Phase 2Results posted